• LAST PRICE
    1.2600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.1800/ 2
  • Ask / Lots
    1.4200/ 2
  • Open / Previous Close
    0.0000 / 1.2600
  • Day Range
    ---
  • 52 Week Range
    Low 0.8906
    High 3.1400
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1.275
TimeVolumePSNL
09:32 ET71621.275
09:36 ET1001.29
09:38 ET1001.295
09:39 ET14381.305
09:48 ET16001.305
09:52 ET6001.29
09:54 ET15971.29
09:56 ET29931.29
09:57 ET10001.29
09:59 ET41801.3
10:01 ET1001.29
10:06 ET14591.29
10:08 ET5001.28
10:10 ET5001.2799
10:12 ET1321.2788
10:17 ET12161.28
10:19 ET101001.285
10:21 ET4001.285
10:28 ET100001.285
10:30 ET102891.3
10:32 ET1181.295
10:37 ET9001.3
10:46 ET68931.2997
10:51 ET39011.295
10:55 ET4001.298
11:00 ET20001.295
11:02 ET10001.28
11:04 ET4001.28
11:06 ET61001.28
11:08 ET7841.27
11:18 ET1001.28
11:24 ET16651.26
11:26 ET50001.2618
11:27 ET14631.27
11:31 ET7001.28
11:33 ET9701.2886
11:40 ET10931.285
11:42 ET4751.2828
11:45 ET1001.285
12:00 ET8001.29
12:07 ET1001.29
12:09 ET1001.29
12:12 ET1001.295
12:16 ET7221.295
12:20 ET6001.295
12:21 ET9551.295
12:23 ET8251.28
12:27 ET2001.28
12:30 ET1001.28
12:32 ET63001.285
12:36 ET2001.28
12:38 ET3001.28
12:39 ET19471.285
12:41 ET1001.28
12:43 ET50001.28
12:45 ET2001.285
12:48 ET156181.26
12:50 ET2001.26
12:52 ET3001.26
12:54 ET11001.265
12:56 ET18001.26
12:57 ET14001.265
12:59 ET3151.2612
01:01 ET14001.265
01:03 ET10001.26
01:06 ET8001.26
01:15 ET10001.27
01:17 ET47361.2648
01:19 ET7951.265
01:32 ET41001.265
01:33 ET1001.265
01:37 ET1001.265
01:48 ET1001.26
01:51 ET2941.26
01:53 ET2001.265
01:55 ET2061.265
02:02 ET3971.26
02:04 ET5061.265
02:08 ET1001.27
02:09 ET4001.2601
02:13 ET3001.26
02:15 ET9001.265
02:18 ET9001.27
02:22 ET5001.265
02:26 ET1001.27
02:29 ET8361.26
02:31 ET20521.25
02:36 ET4001.25
02:38 ET4001.255
02:40 ET12001.26
02:44 ET243331.245
02:45 ET198921.255
02:47 ET18001.255
02:51 ET5001.255
02:56 ET1001.255
03:02 ET5001.255
03:03 ET13451.255
03:05 ET12001.255
03:07 ET3001.255
03:09 ET5971.255
03:12 ET14521.25
03:14 ET3001.255
03:16 ET38241.255
03:18 ET3001.25
03:20 ET101171.245
03:21 ET13001.245
03:23 ET8001.25
03:25 ET3001.255
03:27 ET7001.26
03:30 ET6501.255
03:32 ET8001.255
03:34 ET6001.255
03:36 ET5001.255
03:38 ET6001.25
03:39 ET6001.255
03:41 ET6001.25
03:43 ET17131.25
03:45 ET6001.26
03:48 ET7911.26
03:50 ET2001.26
03:52 ET8081.255
03:54 ET12861.26
03:56 ET14331.26
03:57 ET34401.26
03:59 ET69331.26
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPSNL
Personalis Inc
64.5M
-0.6x
---
United StatesMDXH
MDxHealth SA
64.1M
0.0x
---
United StatesCDTX
Cidara Therapeutics Inc
74.7M
-2.1x
---
United StatesPLX
Protalix Biotherapeutics Inc
83.3M
16.5x
---
United StatesBIOQ
Bioqual Inc
67.1M
-146.6x
-25.28%
United StatesFBIO
Fortress Biotech Inc
35.0M
-0.2x
---
As of 2024-04-16

Company Information

Personalis, Inc. is engaged in developing and marketing advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other next generation cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, the development of personalized cancer therapies.

Contact Information

Headquarters
6600 Dumbarton CircleFREMONT, CA, United States 94555
Phone
650-752-1300
Fax
302-531-3150

Executives

Independent Chairman of the Board
Karin Eastham
President, Chief Executive Officer, Director
Christopher Hall
Chief Financial Officer, Chief Operating Officer, Senior Vice President
Aaron Tachibana
Executive Vice President - Research and Development, Chief Medical Officer
Richard Chen
Vice President, General Counsel, Corporate Secretary
Stephen Moore

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$64.5M
Revenue (TTM)
$73.5M
Shares Outstanding
51.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.96
EPS
$-2.25
Book Value
$2.56
P/E Ratio
-0.6x
Price/Sales (TTM)
0.9
Price/Cash Flow (TTM)
---
Operating Margin
-149.61%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.